KRAS and Branchioma: We herein expand on the spectrum of molecular findings in branchioma, in which we detected 5 pathogenic/likely pathogenic gene mutations, particularly two MSH6 mutations, two PTEN mutations, and one KRAS alteration, indicating molecular heterogeneity in branchioma.